Status:
TERMINATED
Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this clinical research study is to learn if BMS-275183 can shrink or slow the growth of the cancer in subjects with non-small cell lung cancer (NSCLC). The safety of this treatment will...
Eligibility Criteria
Inclusion
- Advanced or metastatic pretreated NSCLC
- Measurable disease
- Adequate hematologic, hepatic and renal functions
- ECOG Performance Status of 0-2
Exclusion
- Inability to swallow capsules
- Recent significant cardiovascular disease
- Woman who are pregnant or breastfeeding
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00099879
Last Update
March 2 2010
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Sacramento, California, United States
2
Local Institution
New Haven, Connecticut, United States
3
Local Institution
Atlanta, Georgia, United States
4
Local Institution
Maywood, Illinois, United States